These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 6146768)

  • 1. Cardiotoxicity associated with mitoxantrone.
    Stuart-Harris R; Pearson M; Smith IE; Olsen EG
    Lancet; 1984 Jul; 2(8396):219-20. PubMed ID: 6146768
    [No Abstract]   [Full Text] [Related]  

  • 2. Potential cardiotoxicity with mitoxantrone.
    Schell FC; Yap HY; Blumenschein G; Valdivieso M; Bodey G
    Cancer Treat Rep; 1982 Aug; 66(8):1641-3. PubMed ID: 7105054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac evaluation of mitoxantrone.
    Unverferth DV; Unverferth BJ; Balcerzak SP; Bashore TA; Neidhart JA
    Cancer Treat Rep; 1983 Apr; 67(4):343-50. PubMed ID: 6850653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical safety and tolerance of mitoxantrone (Novantrone).
    Crossley RJ
    Cancer Treat Rev; 1983 Dec; 10 Suppl B():29-36. PubMed ID: 6362875
    [No Abstract]   [Full Text] [Related]  

  • 5. Mitoxantrone (novantrone): a review of experimental and early clinical studies.
    Smith IE
    Cancer Treat Rev; 1983 Jun; 10(2):103-15. PubMed ID: 6347376
    [No Abstract]   [Full Text] [Related]  

  • 6. Phase II trial of mitoxantrone in advanced sarcomas: a Southwest Oncology Group study.
    Bull FE; Von Hoff DD; Balcerzak SP; Stephens RL; Panettiere FJ
    Cancer Treat Rep; 1985 Feb; 69(2):231-3. PubMed ID: 3882233
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of mitoxantrone cardiac toxicity by nuclear angiography and endomyocardial biopsy: an update.
    Benjamin RS; Chawla SP; Ewer MS; Carrasco CH; Mackay B; Holmes F
    Invest New Drugs; 1985; 3(2):117-21. PubMed ID: 4019116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective alopecia with mitoxantrone.
    Arlin ZA; Friedland ML; Atamer MA
    N Engl J Med; 1984 May; 310(22):1464. PubMed ID: 6717533
    [No Abstract]   [Full Text] [Related]  

  • 9. Allergic reactions to mitoxantrone.
    Taylor WB; Cantwell BM; Roberts JT; Harris AL
    Lancet; 1986 Jun; 1(8495):1439. PubMed ID: 2872535
    [No Abstract]   [Full Text] [Related]  

  • 10. Fatal congestive heart failure following mitoxantrone treatment in two children previously treated with doxorubicin and cisplatin.
    Pratt CB; Crom DB; Wallenberg J; Sanyal SK; Miliauskas J; Sohlberg K
    Cancer Treat Rep; 1983 Jan; 67(1):85-8. PubMed ID: 6684503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitoxantrone--a critique.
    Holland JF
    Cancer Treat Rev; 1983 Dec; 10 Suppl B():77-9. PubMed ID: 6661738
    [No Abstract]   [Full Text] [Related]  

  • 12. Mitoxantrone hydrochloride in lymphoma.
    Coltman CA; McDaniel TM; Balcerzak SP; Morrison FS; Von Hoff DD
    Cancer Treat Rev; 1983 Dec; 10 Suppl B():73-6. PubMed ID: 6661737
    [No Abstract]   [Full Text] [Related]  

  • 13. Potential cardiotoxicity with the use of DuP-941: a case report.
    Walsh SM; Walley VM; Chandra L; Huan SD; Veinot JP; Higginson LA
    Can J Cardiol; 1995 May; 11(5):419-22. PubMed ID: 7750038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitoxantrone in the treatment of relapsed and refractory acute leukemia.
    Ehninger G; Ho AD; Meyer P; Mjaaland I; Ostendorf P; Seither E
    Onkologie; 1985 Jun; 8(3):146-8. PubMed ID: 3895096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II study of mitoxantrone in patients with metastatic breast carcinoma: a Southeastern Cancer Study Group project.
    Smalley R; Gams R
    Cancer Treat Rep; 1983 Nov; 67(11):1039-40. PubMed ID: 6640553
    [No Abstract]   [Full Text] [Related]  

  • 16. Mitozantrone-induced asteatosis.
    Dharmasena F; Chu AC; Goldman JM; Galton DA
    Lancet; 1985 Jul; 2(8446):101. PubMed ID: 2861514
    [No Abstract]   [Full Text] [Related]  

  • 17. Mitoxantrone in malignant melanoma.
    Presant CA; Gams R; Bartolucci A
    Cancer Treat Rep; 1984 Jun; 68(6):903-5. PubMed ID: 6733704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II evaluation of mitoxantrone in patients with bronchogenic carcinoma: a Southeastern Cancer Study Group trial.
    Kramer BS; Gams R; Birch R; Einhorn L; Buchanan R
    Cancer Treat Rep; 1984 Oct; 68(10):1295-6. PubMed ID: 6525601
    [No Abstract]   [Full Text] [Related]  

  • 19. Phase II trial of mitoxantrone in refractory germ cell tumors: a trial of the Southeastern Cancer Study Group.
    Williams SD; Birch R; Gams R; Irwin L
    Cancer Treat Rep; 1985 Dec; 69(12):1455-6. PubMed ID: 3000593
    [No Abstract]   [Full Text] [Related]  

  • 20. Phase II trial of mitoxantrone in advanced colorectal cancer.
    Bonnem EM; Mitchell EP; Woolley PV; Smith FP; Neefe J; Smith L; Schein PS
    Cancer Treat Rep; 1982 Nov; 66(11):1995-6. PubMed ID: 7139642
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.